{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981470108425984.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.clinthera.2017.01.004"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0149291817300371?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0149291817300371?httpAccept=text/plain"}}],"dc:title":[{"@value":"Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function−associated Multi-organ Autoimmune Syndrome"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381981470108426115","@type":"Researcher","foaf:name":[{"@value":"Tawfik Khoury"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470108426116","@type":"Researcher","foaf:name":[{"@value":"Vered Molho-Pessach"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470108426113","@type":"Researcher","foaf:name":[{"@value":"Yuval Ramot"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470108426114","@type":"Researcher","foaf:name":[{"@value":"Abu Rmeileh Ayman"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470108426118","@type":"Researcher","foaf:name":[{"@value":"Orly Elpeleg"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470108426119","@type":"Researcher","foaf:name":[{"@value":"Neville Berkman"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470108426117","@type":"Researcher","foaf:name":[{"@value":"Abraham Zlotogorski"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470108426112","@type":"Researcher","foaf:name":[{"@value":"Yaron Ilan"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01492918"}],"prism:publicationName":[{"@value":"Clinical Therapeutics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2017-02","prism:volume":"39","prism:number":"2","prism:startingPage":"444","prism:endingPage":"449"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0149291817300371?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0149291817300371?httpAccept=text/plain"}],"createdAt":"2017-01-30","modifiedAt":"2018-09-04","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/2050588892102154624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Tocilizumab-induced immunocomplex glomerulonephritis : a report of two cases"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.clinthera.2017.01.004"},{"@type":"CROSSREF","@value":"10.1007/s13730-020-00478-6_references_DOI_GiU5ivb9wGsPaPcFrIASwMqaoAs"}]}